机译:乳头状肾细胞癌中的免疫相关LNCRNA预后模型:LNCRNA表达分析
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Fujian Med Univ Dept Urol Affiliated Hosp 1 Fuzhou 350005 Peoples R China;
Immune; Papillary renal cell carcinoma; Long non-coding RNA; Prognosis; Bioinformatics;
机译:食管鳞状细胞癌患者七升相线签名的预后价值:LNCRNA表达分析
机译:基于机器学习的头颈鳞状细胞癌的诊断和预后价值筛选键LNCRNA和MRNA-LNCRNA共表达网络分析
机译:一种新型免疫相关的LNCRNA基模型,用于清除细胞肾细胞癌中的存活预测
机译:基于呼吸细胞肾细胞癌患者的基于贝叶斯网络的基于贝叶斯网络
机译:了解乳头状肾细胞癌亚型的属性:分子分析,生物标志物发现及其对治疗的意义
机译:长期非编码RNA谱研究鉴定了肾肾透明细胞癌的免疫相关LNCRNA预后签名
机译:基于RNA测序数据,鉴定12个免疫相关的LNCRNA和用于透明细胞肾细胞癌的分子亚型
机译:新型肿瘤抗原和Foxp3双靶向肿瘤细胞疫苗增强了小鼠肾细胞癌模型的免疫治疗。